Real-time imaging of platelet dynamics in engineered arterial, venous, and cancer-associated thrombotic microenvironments
Source abstract
Abstract
Abstract Thrombosis is a leading cause of cardiovascular morbidity and mortality, driven by platelet-mediated mechanisms common across distinct vascular environments. However, the dynamical behavior of platelets during thrombogenesis remains poorly understood due to the lack of a comprehensive analytical framework. Here we present a physiologically relevant, imaging-integrated thrombosis-on-a-chip platform that enables real-time quantitative analysis of platelet dynamics during thrombogenesis under arterial, venous, and cancer-associated conditions. The system incorporates endothelialized 3D-printed vascular geometries into a closed-loop whole-blood perfusion circuit that replicates native hemodynamic and cellular microenvironments. Multimodal imaging captures the spatiotemporal evolution of thrombus formation and shows how hydrodynamic forces, endothelial dysfunction, and tumor-derived factors drive distinct thrombotic signatures. Notably, platelet-endothelium adhesion and circulating platelet aggregation are identified as mechanistically distinct yet closely linked processes, each uniquely modulated by vascular context. This platform offers a robust framework for dissecting thrombogenesis and advancing antithrombotic and cancer-associated thrombosis research.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Platelet Disorders and Treatments · Blood properties and coagulation · Angiogenesis and VEGF in Cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (64)
Show source-provided references
1. Triggers, targets and treatments for thrombosis10.1038/nature06797 ↗
2. Global burden of thrombosis: epidemiologic aspects10.1161/CIRCRESAHA.115.306841 ↗
3. Thrombosis and cancer10.1038/nrclinonc.2012.106 ↗
4. Epidemiology and pathophysiology of cancer-associated thrombosis10.1038/sj.bjc.6605599 ↗
5. Risk of arterial thromboembolism in patients with cancer10.1016/j.jacc.2017.06.047 ↗
6. Platelet physiology and thrombosis10.1016/j.thromres.2004.07.020 ↗
7. Platelets at the interface of thrombosis, inflammation, and cancer10.1182/blood-2014-08-531582 ↗
8. Adhesion mechanisms in platelet function10.1161/01.RES.0000267878.97021.ab ↗
9. The growing complexity of platelet aggregation10.1182/blood-2006-12-027698 ↗
10. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets10.1038/359848a0 ↗
11. The role of leukocytes in thrombosis10.1182/blood-2016-05-718114 ↗
12. Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα10.1038/ncomms15559 ↗
13. Platelets in atherothrombosis10.1038/nm1102-1227 ↗
14. A shear gradient-activated microfluidic device for automated monitoring of whole blood haemostasis and platelet function10.1038/ncomms10176 ↗
15. Role of von Willebrand factor (VWF), platelets, and aberrant flow in the initiation of venous thrombosis10.1126/sciadv.adr5250 ↗
16. Platelets drive thrombus propagation in a hematocrit and glycoprotein VI–dependent manner in an in vitro venous thrombosis model10.1161/ATVBAHA.118.310731 ↗
17. Contribution of platelets to tumour metastasis10.1038/nrc3004 ↗
18. Platelets favor the outgrowth of established metastases10.1038/s41467-024-47516-w ↗
19. Thrombosis-on-a-chip: a new way to model a complex process10.1182/blood.V130.Suppl_1.SCI-10.SCI-10 ↗
20. Thrombosis-on-a-chip: prospective impact of microphysiological models of vascular thrombosis10.1016/j.cobme.2017.12.001 ↗
21. Animal models of thrombosis from zebrafish to nonhuman primates: use in the elucidation of new pathologic pathways and the development of antithrombotic drugs10.1161/CIRCRESAHA.115.306823 ↗
22. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse10.1038/nm782 ↗
23. Critical review of mouse models of venous thrombosis10.1161/ATVBAHA.111.244608 ↗
24. In vivo thrombus formation in murine models10.1161/01.RES.0000261936.85776.5f ↗
25. Measurement of whole blood thrombus formation using parallel-plate flow chambers—a practical guide10.3109/09537104.2011.630848 ↗
26. Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner10.1073/pnas.1209905110 ↗
27. Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension10.1182/blood-2002-05-1550 ↗
28. Clinically relevant clot resolution via a thromboinflammation-on-a-chip10.1038/s41586-025-08804-7 ↗
29. Multi-parametric thrombus profiling microfluidics detects intensified biomechanical thrombogenesis associated with hypertension and aging10.1038/s41467-024-53069-9 ↗
30. Resolving the multifaceted mechanisms of the ferric chloride thrombosis model using an interdisciplinary microfluidic approach10.1182/blood-2015-02-628594 ↗
31. Microengineered human vein‐chip recreates venous valve architecture and its contribution to thrombosis10.1002/smll.202003401 ↗
32. Visualizing thrombosis to improve thrombus resolution10.1002/rth2.12469 ↗
33. Massive image-based single-cell profiling reveals high levels of circulating platelet aggregates in patients with COVID-1910.1038/s41467-021-27378-2 ↗
34. Direct evaluation of antiplatelet therapy in coronary artery disease by comprehensive image-based profiling of circulating platelets10.1038/s41467-025-59664-8 ↗
35. Intelligent platelet morphometry10.1016/j.tibtech.2020.12.012 ↗
36. Intelligent classification of platelet aggregates by agonist type10.7554/eLife.52938 ↗
37. Intelligent image-activated cell sorting10.1016/j.cell.2018.08.028 ↗
38. High-throughput fluorescence lifetime imaging flow cytometry10.1038/s41467-024-51125-y ↗
39. Quantitative phase imaging in biomedicine10.1038/s41566-018-0253-x ↗
40. Studying the efficacy of antiplatelet drugs on atherosclerosis by optofluidic imaging on a chip10.1039/D2LC00895E ↗
41. Recapitulating atherogenic flow disturbances and vascular inflammation in a perfusable 3D stenosis model10.1088/1758-5090/aba501 ↗
42. New insights into the mechanisms of venous thrombosis10.1172/JCI60229 ↗
43. Venous thrombosis10.1038/nrdp.2015.6 ↗
44. Understanding stenosis-induced platelet aggregation on a chip by high-speed optical imaging10.1016/j.snb.2021.131318 ↗
45. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers10.1073/pnas.0608422104 ↗
46. von Willebrand factor–mediated platelet adhesion is critical for deep vein thrombosis in mouse models10.1182/blood-2010-05-287623 ↗
47. Platelet integrin αIIbβ3 plays a key role in a venous thrombogenesis mouse model10.1038/s41467-024-52869-3 ↗
48. Expression of tumor necrosis factor-α in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1α10.1161/01.ATV.20.2.410 ↗
49. Underlying mechanisms of thrombus formation/growth in atherothrombosis and deep vein thrombosis10.1111/pin.13305 ↗
50. Endothelial dysfunction: a marker of atherosclerotic risk10.1161/01.ATV.0000051384.43104.FC ↗
51. Role of endothelial dysfunction in atherosclerosis10.1161/01.CIR.0000131515.03336.f8 ↗
52. Endothelial dysfunction drives atherosclerotic plaque macrophage-dependent abdominal aortic aneurysm formation10.1038/s41590-025-02132-8 ↗
53. Endothelial cell control of thrombosis10.1186/s12872-015-0124-z ↗
54. Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity10.1016/j.jtha.2023.02.029 ↗
55. Thrombosis in ovarian cancer: a case control study10.1038/bjc.2014.3 ↗
56. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients10.1002/cncr.23062 ↗
57. Platelets guide the formation of early metastatic niches10.1073/pnas.1411082111 ↗
58. The dynamic role of platelets in cancer progression and their therapeutic implications10.1038/s41568-023-00639-6 ↗
59. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update10.1200/JCO.19.01461 ↗
60. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow10.1182/blood-2004-01-0107 ↗
61. Inflammation, von Willebrand factor, and ADAMTS1310.1182/blood-2018-02-769000 ↗
62. Role of platelets in cancer and cancer-associated thrombosis: experimental and clinical evidences10.1016/j.thromres.2016.01.006 ↗
63. Cancer-related arterial thromboembolic events10.1016/j.acvd.2023.11.007 ↗
64. Real-time imaging of platelet dynamics in engineered arterial, venous, and cancer-associated thrombotic microenvironments10.5281/zenodo.15654413) ↗